The article discusses the prevention of thiazide-induced hypergylcemia. It mentions that thiazide diuretics, which have been used as the first-line therapy for hypertension, have experienced a decline in its use in the 1980s and 1990s caused by its metabolic effects and entry of newer agents. Physicians have banned the use of such drugs in hypertension treatment as there have been cases wherein patients developed diabetes after thiazide therapy. It stresses that factors aside from the drug such as lifestyle choices tend to contribute to diabetes.